Molecular characteristics of Staphylococcus aureus isolated from a major hospital in Lebanon

dc.contributor.authorHarastani, Houda H.
dc.contributor.authorAraj, George F.
dc.contributor.authorTokajian, Sima T.
dc.contributor.departmentPathology and Laboratory Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:09:50Z
dc.date.available2025-01-24T12:09:50Z
dc.date.issued2014
dc.description.abstractObjectives: The occurrence and dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare settings and the community and its risk of being introduced into hospitals are matters of great concern. The purpose of this study was to conduct a miniaturized epidemiological analysis of S. aureus-associated infections and to characterize the isolates by a variety of molecular typing techniques. Ongoing molecular surveillance is essential to prevent S. aureus strains from becoming endemic in the Lebanese healthcare setting. Methods: A total of 132 S. aureus from different clinical specimens were isolated over a 6-month period. Characterization of the isolates was done by detection of the mecA gene, Panton-Valentine leukocidin determinant detection, staphylococcal chromosomal cassette (SCC. mec) typing of MRSA, S. aureus protein A (spa) typing, multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), and antibiogram analysis. Results: MRSA represented 30% of the isolates, with PVL being detected in 54% of MRSA and 12% of methicillin-susceptible S. aureus (MSSA). A difference between MRSA and MSSA was observed in the spa types. Clustering SCC. mec with MLST identified seven MRSA and 20 MSSA clones, with PVL-positive ST80-MRSA-IV being the dominant clone (7%), while PFGE revealed 32 groups with 80% cutoff similarity. Conclusions: Although the results of this study are based on samples collected from one hospital, the high diversity observed along with the lack of any equivalence in the genetic backgrounds of the major MSSA and MRSA clones, emphasizes the urgent need for standardized surveillance combined with the application of well-validated typing methods to assess the occurrence of MRSA and subsequently to control its spread. © 2013 The Authors.
dc.identifier.doihttps://doi.org/10.1016/j.ijid.2013.10.007
dc.identifier.eid2-s2.0-84892855268
dc.identifier.pmid24280321
dc.identifier.urihttp://hdl.handle.net/10938/32145
dc.language.isoen
dc.relation.ispartofInternational Journal of Infectious Diseases
dc.sourceScopus
dc.subjectMlst
dc.subjectPfge
dc.subjectSccmec
dc.subjectSpa typing
dc.subjectSt80-mrsa-iv
dc.subjectStaphylococcus aureus
dc.subjectAnti-bacterial agents
dc.subjectAntigens, bacterial
dc.subjectBacterial proteins
dc.subjectBacterial toxins
dc.subjectBacterial typing techniques
dc.subjectCluster analysis
dc.subjectDna, bacterial
dc.subjectElectrophoresis, gel, pulsed-field
dc.subjectExotoxins
dc.subjectFemale
dc.subjectGenotype
dc.subjectHumans
dc.subjectLebanon
dc.subjectLeukocidins
dc.subjectMale
dc.subjectMethicillin-resistant staphylococcus aureus
dc.subjectMicrobial sensitivity tests
dc.subjectMolecular epidemiology
dc.subjectMultilocus sequence typing
dc.subjectStaphylococcal infections
dc.subjectVirulence factors
dc.subjectAmoxicillin plus clavulanic acid
dc.subjectCefalotin
dc.subjectCiprofloxacin
dc.subjectClindamycin
dc.subjectCotrimoxazole
dc.subjectErythromycin
dc.subjectOxacillin
dc.subjectPanton valentine leukocidin
dc.subjectRifampicin
dc.subjectStaphylococcus protein a
dc.subjectTeicoplanin
dc.subjectTetracycline
dc.subjectVancomycin
dc.subjectAntiinfective agent
dc.subjectBacterial antigen
dc.subjectBacterial dna
dc.subjectBacterial protein
dc.subjectBacterial toxin
dc.subjectExotoxin
dc.subjectLeukocidin
dc.subjectMeca protein, staphylococcus aureus
dc.subjectPanton-valentine leukocidin
dc.subjectStreptococcal protective antigen
dc.subjectVirulence factor
dc.subjectGentamicin
dc.subjectAntibiotic sensitivity
dc.subjectArticle
dc.subjectBacterial gene
dc.subjectBacterial strain
dc.subjectBacterium isolate
dc.subjectBacterium isolation
dc.subjectControlled study
dc.subjectEndemic disease
dc.subjectGene cassette
dc.subjectHospital
dc.subjectHuman
dc.subjectMajor clinical study
dc.subjectMethicillin resistant staphylococcus aureus
dc.subjectMethicillin susceptible staphylococcus aureus
dc.subjectMolecular cloning
dc.subjectMolecular typing
dc.subjectNonhuman
dc.subjectPulsed field gel electrophoresis
dc.subjectSkin infection
dc.subjectSoft tissue infection
dc.subjectStaphylococcus infection
dc.subjectBacterium identification
dc.subjectChemistry
dc.subjectClassification
dc.subjectDrug effects
dc.subjectGenetics
dc.subjectIsolation and purification
dc.subjectMicrobial sensitivity test
dc.subjectMicrobiology
dc.subjectAntibiotic resistance
dc.subjectLebanese
dc.subjectMethicillin resistant staphylococcus aureus infection
dc.subjectStaphylococcal skin infection
dc.titleMolecular characteristics of Staphylococcus aureus isolated from a major hospital in Lebanon
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2014-10668.pdf
Size:
1.19 MB
Format:
Adobe Portable Document Format